Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Flagship Pioneering
Biotech
Novartis pens ProFound pact for cardiovascular disease targets
Novartis is doling out $25 million in upfront and near-term milestone payments while tacking on the chance to make up to $750 million per target.
Gabrielle Masson
Jun 26, 2025 6:30am
Scholar Rock rocks the boat with new execs—Chutes & Ladders
May 2, 2025 8:30am
Etiome emerges with $50M from Flagship, plans to preempt disease
Apr 24, 2025 6:00am
Genentech builds autoimmune Repertoire with $765M deal
Apr 23, 2025 7:00am
J&J innovator vaults to Valo—Chutes & Ladders
Apr 11, 2025 8:30am
Flagship's Sail Biomedicines lays off 12 staffers
Apr 1, 2025 3:44pm
